Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) · MU Plovdiv

10. MPN. Essential Thrombocythemia and Myelofibrosis

Inside: 3 sections · 3 tables · 1 flashcard · 4 min

Topic 59 of 68 in the MU Plovdiv syllabus for Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) (Medicine, Year 4). The free AceMed note covers it in 3 sections, about 553 words (4 min of reading), with 1 flashcard.

In this note

  1. Essay 10- MPN. Essential thrombocythaemia and myelofibrosis
  2. Essential thrombocythaemia
  3. Primary myelofibrosis

Essay 10- MPN. Essential thrombocythaemia and myelofibrosis

What are MPNs?

  • The abnormal proliferation of one or more terminal myeloid cell lines in the peripheral blood gives rise to a heterogeneous group of disorders called myeloproliferative neoplasms:
  • Chronic myeloid leukemia
  • Polycythaemia vera
  • Essential thrombocythaemia
  • Primary myelofibrosis

Essential thrombocythaemia

Definition

  • Condition in which there is a sustained increase in the platelet count due to megakaryocyte proliferation and overproduction!

Etiology

  • Overproduction of hematopoietic cells due to the mutations of the JAK2, CALR, or MPL genes
  • Most have JAK-2

Symptoms

  • Various levels of thrombosis (hepatic vein thrombosis)
  • Headache
  • Visual changes
  • Fatigue
  • Burning sensation felt in the hands or feet and promptly relieved by aspirin
  • Insomnia
  • Migraines
  • Dizziness
  • TIA
  • Erythromegalia
  • Easy bruising

Diagnosis

  • The suggested diagnostic criteria are:
  • A1- Sustained platelet count above 450 × 109/L.
  • A2- Presence of an acquired pathogenetic mutation (e.g. in JAK2 or CALR).
  • A3- No other myeloid malignancy, PV, primary myelofibrosis, chronic myeloid leukaemia (CML) or myelodysplastic syndrome.
  • A4- No reactive cause for thrombocytosis and normal iron stores.
  • A5- Bone marrow trephine histology showing increased megakaryocytes with prominent large hyperlobulated forms; reticulin is generally not increased.
  • Diagnosis requires A1–A3 or A1 + A3–A5!
  • Blood film- abnormally large platelets and megakaryocyte fragments
  • Bone marrow- similar to PV but there is an excess of abnormal megakaryocytes!
  • Testing for genetic mutation

Treatment

  • Principle is to reduce risk of major clinical problems of thrombosis or hemorrhage
  • Identify CV risk factors and treat them (cholesterol, smoking, obesity, HTN
  • Low dose aspirin in all cases!
  • High risk patients- treat with hydroxycarbamide or anagrelide to reduce platelet count
  • Over 60
  • With previous thrombosis
  • Platelet count greater than 1500
  • Hydroxycarbamide is the most widely used treatment and is well tolerated
  • Side effects (prolonged therapy)- skin keratosis, epitheliomas, ulceration, pigmentation
  • Anagrelide is a good second‐line treatment but has cardiovascular side‐effects

Continue reading free

The whole note, all 3 sections, is free with an AceMed account, with its 1 flashcard. Premium adds flashcard recall, highlights and Ask AI.